as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹32.44
Change
+0.11 (0.34%)
Open
₹32.11
Prev. Close
₹32.33
Day High
₹32.98
Day Low
₹32.11
Volume Analysis
Traded
5,741
Delivered
3,961
Delivery %
68.99%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹33.78 | ₹33.38 | ₹32.91 | ₹32.51 | ₹32.04 | ₹31.64 | ₹31.17 |
| Fibonacci | ₹33.38 | ₹33.05 | ₹32.84 | ₹32.51 | ₹32.18 | ₹31.97 | ₹31.64 |
| Camarilla | ₹32.68 | ₹32.6 | ₹32.52 | ₹32.51 | ₹32.36 | ₹32.28 | ₹32.2 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-1.64%
1 Week
-0.52%
1 Month
-1.49%
3 Months
-7.16%
6 Months
+17.75%
1 Year
-21.87%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Sector
Healthcare
Source: Screener.in (Consolidated figures) — data as of 23 Sep 2026. Not investment advice.
TopFund Analysis
Biofil Chem & Pharma Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 54/100. The strongest factor is Corporate Governance (85/100), while Institutional Ownership (30/100) is the weakest area to weigh before deciding.
TopFund Score — Fundamentals Quality
54/100 — AverageData confidence: 60/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Corporate Governance
Institutional Ownership
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Pursuant to Regulation 30, 44 and 47 of SEBI(LODR) Regulations, 2015 and in compliance with Section 108 of the Companies Act, 2013 read with rule …
41st AGM on 23 September 2026; annual report and notice shared with shareholders lacking registered emails.
Company issued 2025-26 annual report; 41st AGM on 23 Sept 2026, including ₹20 crore related-party approval.
Source: BSE regulatory filings, via Screener.in.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 53.1% | 53.11% | 53.08% | 53.11% | 53.1% | 53.11% | 53.11% | 53.1% | 53.12% | 53.13% | 53.12% | 53.13% |
| Promoters | 46.82% | 46.82% | 46.82% | 46.82% | 46.82% | 46.82% | 46.82% | 46.82% | 46.79% | 46.79% | 46.79% | 46.79% |
| FII | 0.0% | 0.0% | 0.03% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| DII | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Biofil Chem & Pharma Ltd (this stock) | — | — | — | — |
| Sun Pharmaceutical Ind L | 444,405 | 35.2 | 5.32 | 16.0% |
| Divi S Laboratories Ltd | 255,487 | 85.8 | 15.25 | 16.5% |
| Torrent Pharmaceuticals L | 189,746 | 85.0 | 20.11 | 27.4% |
| Apollo Hospitals Enter. L | 128,055 | 60.9 | 13.51 | 21.2% |
| Zydus Lifesciences Ltd | 115,890 | 23.8 | 4.32 | 21.2% |
| Cipla Ltd | 111,060 | 31.0 | 3.23 | 11.6% |
Which Mutual Funds Hold Biofil Chem & Pharma Ltd?
Frequently Asked Questions about Biofil Chem & Pharma Ltd
Biofil Chem & Pharma Ltd (BIOFILCHEM) closed at ₹32.44 on NSE on 25 September 2026, up 0.11 (0.34%) from the previous close.
Biofil Chem & Pharma Ltd trades on the NSE (National Stock Exchange of India) under the symbol BIOFILCHEM.
Biofil Chem & Pharma Ltd has a TopFund Quality Score of 54/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Biofil Chem & Pharma Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.